Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4basebio Plc Share News (4BB)

Share Price Information for 4basebio Plc (4BB)

Share Price is delayed by 15 minutes
Get Live Data
525.00    0.00 (0.00%)
Bid:
500.00
Ask:
550.00
Spread: 50.00 (10.00%)
Market Cap: £81.30m
4BB Live PriceLast checked at - London Stock Exchange

Intraday 4basebio Plc Share Chart

4basebio Plc News

4basebio inks supply deal with Italy's Neomatrix
25 May 2023

4basebio inks supply deal with Italy's Neomatrix

(Sharecast News) - Synthetic DNA biotechnology specialist 4basebio announced a product supply agreement with Neomatrix on Thursday, which it described...

TRADING UPDATES: abrdn Property's NAV rises; Foresight VCT's falls
4 Oct 2022

TRADING UPDATES: abrdn Property's NAV rises; Foresight VCT's falls

(Alliance News) - The following is a round-up of earnings updates by London-listed companies, issued last week and not separately reported by Alliance...

IN BRIEF: 4basebio and universities team up against Neurofibromatosis
10 Jun 2022

IN BRIEF: 4basebio and universities team up against Neurofibromatosis

4basebio PLC - Heidelberg, Germany-based life sciences company - Teams up with the University of Alabama and England-based Teesside University for a r...

4basebio enters neurofibromatosis collaboration with two universities
10 Jun 2022

4basebio enters neurofibromatosis collaboration with two universities

(Sharecast News) - Life sciences company 4basebio announced a collaboration with the University of Alabama (UA) and Teesside University (TU) on Friday...

Losses to continue as 4basebio focuses on commercialisation
9 May 2022

Losses to continue as 4basebio focuses on commercialisation

(Sharecast News) - Specialist DNA-focussed life sciences company 4basebio reported revenue of £0.34m in its final results on Monday, down from &#...

IN BRIEF: 4Basebio annual loss balloons amid research investment
9 May 2022

IN BRIEF: 4Basebio annual loss balloons amid research investment

4Basebio PLC - Heidelberg, Germany-based life sciences company - Nearly quintuples annual loss. 2021 pretax loss widens to GBP3.6 million from GBP716,...

4basebio inks development deal with Heqet Therapeutics
27 Apr 2022

4basebio inks development deal with Heqet Therapeutics

(Sharecast News) - Life sciences company 4basebio announced a joint development agreement with Heqet Therapeutics on Wednesday.